Researchers studied Lingguizhugan decoction, a traditional Chinese herbal remedy, for its potential in treating Alzheimer's disease by influencing the gut-brain axis through gut microbiota modulation. This ancient remedy may offer novel therapeutic possibilities for AD.
Researchers investigated the bioactive compounds in Atractylodes macrocephala to understand its medicinal benefits for gastrointestinal issues. Identifying these compounds may lead to improved treatment options for digestive disorders.
Chinese medicine, when combined with other treatments, is effective in treating non-small cell lung cancer by reducing toxicity and increasing efficiency. Key components include Astragalus membranaceus, Wolfiporia cocos, and Atractylodes macrocephala, with potential therapeutic effects through AKT1 and EGFR targets.
TCM is important in cancer treatment. Network pharmacology helps study interactions of TCM components, useful for understanding multi-pathway and multi-target effects.
AM-A from Koidz induces unique cell death in breast cancer cells through specific pathways, showing potential as a lead compound for therapeutic development.
Koidz herbal medicine combined with IFN-γ inhibits CRC progression by regulating NF-kB p65/PD-L1 pathway. Effective against CRC cells and xenograft tumors in mice, shows potential for tumor immunotherapy.
Researchers studied the effects of ATL III, a compound in Chinese herb Atractylodes macrocephala Koidz, on neuroinflammation and oxidative stress in relation to Alzheimer's disease. Results suggest potential therapeutic benefits.
Tongbian TCM helps with constipation by regulating water transfer in the colon through AQP3. Contains unique herbs like Atractylodes macrocephala and Astragalus membranaceus. Important for treating slow transit constipation.
Atractylenolide-I from Baizhu herb may prevent congenital heart defects in infants of mothers with gestational diabetes. Potential for new preventive and therapeutic treatments.
Atractylenolide II (AT-II) inhibits endometrial cancer cell growth and glycolysis, induces apoptosis by blocking PADI3-ERK pathway. AT-II may be a potential novel therapy for endometrial cancer.
ATL III, a compound in Atractylodes macrocephala, inhibits migration and invasion of cervical cancer cells by regulating IGF2BP3 through ETV5. This has potential implications for cervical cancer treatment.
Researchers studied the use of traditional plant-based medicines to prevent nerve damage caused by chemotherapy. Results are unclear due to different medicine combinations and lack of understanding of their mechanisms.
Study investigated the effects of Atractylenolide I, Atractylenolide III, and Paeoniflorin on promoting angiogenesis after stroke. Findings could contribute to potential therapies for improving outcomes in stroke patients.
Researchers investigated the effect of Tong-Xie-Yao-Fang (TXYF), a traditional Chinese medicine formula, on colorectal cancer (CRC) accompanied by psychological stress. TXYF improved depression and reduced intestinal symptoms, suggesting its potential as an intervention for CRC patients with psychological stress.
A Chinese herbal feed additive (TCM) improved egg production, quality, antioxidant capacity, immunity, and intestinal health in Roman laying hens compared to control and antibiotic groups.
The researchers studied the LGQH decoction, a traditional Chinese medicine formula, and found it has cardioprotective effects on heart failure. The active ingredients and anti-fibrotic mechanism are still unknown.